![Molecular mechanisms involved in the side effects of fatty acid amide hydrolase inhibitors: a structural phenomics approach to proteome-wide cellular off-target deconvolution and disease association | npj Systems Biology and Applications Molecular mechanisms involved in the side effects of fatty acid amide hydrolase inhibitors: a structural phenomics approach to proteome-wide cellular off-target deconvolution and disease association | npj Systems Biology and Applications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnpjsba.2016.23/MediaObjects/41540_2016_Article_BFnpjsba201623_Fig1_HTML.jpg)
Molecular mechanisms involved in the side effects of fatty acid amide hydrolase inhibitors: a structural phenomics approach to proteome-wide cellular off-target deconvolution and disease association | npj Systems Biology and Applications
![BIA 10-2474 Experimental Drug Molecule. Fatty Acid Amide Hydrolase (FAAH) Inhibitor that Caused Severe Adverse Events in a Stock Illustration - Illustration of neurology, death: 187049010 BIA 10-2474 Experimental Drug Molecule. Fatty Acid Amide Hydrolase (FAAH) Inhibitor that Caused Severe Adverse Events in a Stock Illustration - Illustration of neurology, death: 187049010](https://thumbs.dreamstime.com/z/bia-experimental-drug-molecule-fatty-acid-amide-hydrolase-faah-inhibitor-caused-severe-adverse-events-clinical-trial-187049010.jpg)
BIA 10-2474 Experimental Drug Molecule. Fatty Acid Amide Hydrolase (FAAH) Inhibitor that Caused Severe Adverse Events in a Stock Illustration - Illustration of neurology, death: 187049010
![Computational proteome-wide screening predicts neurotoxic drug-protein interactome for the investigational analgesic BIA 10-2474 - ScienceDirect Computational proteome-wide screening predicts neurotoxic drug-protein interactome for the investigational analgesic BIA 10-2474 - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006291X16321763-fx1.jpg)
Computational proteome-wide screening predicts neurotoxic drug-protein interactome for the investigational analgesic BIA 10-2474 - ScienceDirect
![PDF) What failed BIA 10-2474 Phase I clinical trial? Global speculations and recommendations for future Phase I trials PDF) What failed BIA 10-2474 Phase I clinical trial? Global speculations and recommendations for future Phase I trials](https://i1.rgstatic.net/publication/308410862_What_failed_BIA_10-2474_Phase_I_clinical_trial_Global_speculations_and_recommendations_for_future_Phase_I_trials/links/57ec643a08ae92eb4d265791/largepreview.png)
PDF) What failed BIA 10-2474 Phase I clinical trial? Global speculations and recommendations for future Phase I trials
![BIA 10-2474 experimental drug molecule, illustration - Stock Image - F028/2193 - Science Photo Library BIA 10-2474 experimental drug molecule, illustration - Stock Image - F028/2193 - Science Photo Library](https://media.sciencephoto.com/f0/28/21/93/f0282193-800px-wm.jpg)
BIA 10-2474 experimental drug molecule, illustration - Stock Image - F028/2193 - Science Photo Library
![BIA 10-2474 experimental drug molecule, illustration - Stock Image - F028/2190 - Science Photo Library BIA 10-2474 experimental drug molecule, illustration - Stock Image - F028/2190 - Science Photo Library](https://media.sciencephoto.com/f0/28/21/90/f0282190-800px-wm.jpg)
BIA 10-2474 experimental drug molecule, illustration - Stock Image - F028/2190 - Science Photo Library
![What failed BIA 10-2474 Phase I clinical trial? Global speculations and recommendations for future Phase I trials. - Abstract - Europe PMC What failed BIA 10-2474 Phase I clinical trial? Global speculations and recommendations for future Phase I trials. - Abstract - Europe PMC](https://europepmc.org/articles/PMC5020770/bin/JPP-7-120-g003.jpg)
What failed BIA 10-2474 Phase I clinical trial? Global speculations and recommendations for future Phase I trials. - Abstract - Europe PMC
![BIA 10-2474 experimental drug molecule. Fatty acid amide hydrolase (FAAH) inhibitor that caused severe adverse events in a clinical trial in France in Stock Vector Image & Art - Alamy BIA 10-2474 experimental drug molecule. Fatty acid amide hydrolase (FAAH) inhibitor that caused severe adverse events in a clinical trial in France in Stock Vector Image & Art - Alamy](https://c8.alamy.com/comp/2HFHR3M/bia-10-2474-experimental-drug-molecule-fatty-acid-amide-hydrolase-faah-inhibitor-that-caused-severe-adverse-events-in-a-clinical-trial-in-france-in-2HFHR3M.jpg)
BIA 10-2474 experimental drug molecule. Fatty acid amide hydrolase (FAAH) inhibitor that caused severe adverse events in a clinical trial in France in Stock Vector Image & Art - Alamy
![Discovery of a Potent, Long‐Acting, and CNS‐Active Inhibitor (BIA 10‐2474) of Fatty Acid Amide Hydrolase - Kiss - 2018 - ChemMedChem - Wiley Online Library Discovery of a Potent, Long‐Acting, and CNS‐Active Inhibitor (BIA 10‐2474) of Fatty Acid Amide Hydrolase - Kiss - 2018 - ChemMedChem - Wiley Online Library](https://chemistry-europe.onlinelibrary.wiley.com/cms/asset/426ec923-a43d-45af-8156-72b06a4a0e66/cmdc201800393-toc-0001-m.jpg)